Hierarchies of antigen-specific cytotoxic T-cell responses

Immunological Reviews

Volumn 164, Issue , 1998, Pages 29-32

  Gallimore, Awen ^a,b   Hengartner, Hans ^a   Zinkernagel, Rolf ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0031725572     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01205.x     Document Type: Review

References (48)

1. Van der Most RG, et al. Analysis of cytotoxic T-cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J Immunol 1996;157:5543-5554.
2. Oukka M, et al. Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J Immunol 1996;157:3039-3045.
3. Cole GA, Hogg TL, Coppola MA, Woodland DL. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection. J Immunol 1997;158:4301-4309.
4. b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J Virol 1995;69:6665-6677.
5. b-restricted epitopes. J Immunol 1996;157:5555-5562.
6. Pamer EG, Sijts AJAM, Villanueva MS, Busch DH, Vijh S. MHC class I antigen processing of Litteria monocytogenes proteins: implications for dominant and subdominant CTL responses. Immunol Rev 1997;158:129-136.
7. Vijh S, Pamer EG. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J Immunol 1997;158:3366-3371.
8. Zinkernagel RM, Doherty PC. Restriction of in vitro T-cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974;248:701-702.
9. Townsend A, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986;44:959-968.
10. Sette A, et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T-cell epitopes. J Immunol 1996;153:5586-5592.
11. Eisenlohr LC, Yewdell JW Bennink JR. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J Exp Med 1992;175:481-487.
12. Chen W, Khilko S, Pecondo J, Margulies DH, McCluskey J. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med 1994;180:1471-1483.
13. Restifo NP, et al. Antigen processing in vivo and the elicitation of primary CTL responses. J Immunol 1995;154:4414-1422.
14. Ossendorp F, et al. A single residue exchange within a viral CTL epitope alters proteosome-mediated degradation resulting in lack of antigen presentation. Immunity 1996;5:115-124.
15. Deng Y, Yewdell J, Eisenlohr LC, Benninck JR. MHC affinity, peptide liberation, T-cell repertoire, and immunodminance all contribute to the paucity of MHC class I restricted peptides recognized by antiviral CTL. J Immunol 1997;158:1507-1515.
16. Townsend A, et al. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 1988;168:1211-1224.
17. Tsomides TJ, Aldovini A, Johnson RP, Walker BD, Young RA, Eisen HN. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J Exp Med 1994;180:1283-1293.
18. Levitsky V, Zhang QJ, Levitskaya J, Masucci MG. The life span of major histocompatibility coraplex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J Exp Med 1996;183:915-926.
19. Oldstone M, Whitton JL, Lewicki H, Tishon A. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes. J Exp Med 1988;168:559-570.
20. Klavinskis LS, Whitton JL, Joly E, Oldstone M. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 1990;178:393-400.
21. Pircher HP, Moskophidis D, Rohrer U, Burki K, Hengartner H, Zinkernagel RM. Viral escape by selection of cytotoxic T-cell-resistant virus variants in vivo. Nature 1990;346:629-633.
22. Hany M, et al. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunisation with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur J Immunol 1989;19:417-424.
23. Whitton JL, Gebhard JR, Lewicki H, Tishon A, Oldstone MB. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J Virol 1988;62:687-695.
24. Oldstone MBA, Lewicki H, Borrow P, Hudrisier D, Gairin JE. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J Virol 1995;69:7423-7429.
25. Sloan VS, et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995;376:802-806.
26. Weber DA, Evavold BD, Jensen PE. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 1996;274:618-620.
27. Kropshofer H, Vogt AB, Moldenhauser G, Hammer J, Blum JS, Hämmerling G. Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J 1996;15:6144-6154.
28. Ortmann B, et al. A critical role for tapasin in the assembly and function of multimeric MHC class I-Tap complexes. Science 1997;277:1306-1309.
29. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAO. Immunity 1996;5:103-114.
30. Solheim JC, Harris MR, Kindle CS, Hansen TH. Prominence of β2microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J Immunol 1997;158:2236-2241.
31. Lehner PJ, Surman MJ, Cresswell P. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. Immunity 1998;8:221-231.
32. Van der Most R, et al. Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice. J Virol 1997;71:5110-5114.
33. Sijts AJAM, Pamer EG. Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes. J Exp Med 1997;185:1403-1411.
34. + T cells during an acute virus infection. Immunity 1998;8:167-175.
35. De Campos-Lima P-O, Levitsky V, Imreh MP, Gavioli R, Masucci MG. Epitope-dependent selection of highly restricted or diverse T-cell receptor repertoires in response to persistent infection by Epstein-Barr virus. J Exp Med 1997;186:83-89.
36. Aebischer T, Oehen S, Hengartner H. Preferential usage of V alpha 4 and V beta 10 T-cell receptor genes by LCMV-glycoprotein specific H-2Db restricted cytotoxic T-cells. Eur J Immunol 1990;20:523-531.
37. Moskophidis D, Lechner F, Pircher HP, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362:7S8-761.
38. Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995;375:148-151.
39. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996;273:104-106.
40. Murali-Krishna K, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998;8:177-187.
41. Altman JD, Moss PAH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. Phenotypic analysis of antigen-specific T lymphocytes. Nature 1996;274:94-96.
42. Riddell SR, Watanabe KS, Goodrich JM, Cheng RL, Mounzer EA, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238-241.
43. + Hodgkin's disease. Blood 1997;89:1978-1986.
44. Papadopoulos EB, et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994;330:1185-1191.
45. Battegay M, Moskophidis D, Rahemtulla A, Hengartner H, Mak TW, Zinkernagel RM. Enhanced establishment of a virus carrier state in adult CD4+ T cell deficient mice. J Virol 1994;68:4700-1704.
46. Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci USA 1996;93:4102-4107.
47. Gallimore A, et al. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med 1995;1:1167-1173.
48. Ogg GS, et al. Quantitation of HIV-1 specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998;279:2103-2106.